Lung - Refresher 2021
The management of non-small cell lung cancer has undergone major transformation in the last three years driven by the increasing using of immunotherapy as well as local ablative therapies in advanced stage disease.  Translation of these practices into community based setting is important as overa
Category
  • Lung Cancer
Format
  • Online SA-CME
Credits
  • 1.50 Certificate of Attendance
  • 1.50 SA-CME
Difficult Cases in Small Cell Lung Cancer - 2021 Annual Meeting
Radiation is an integral component of the treatment of small cell lung cancer, as a definitive treatment for limited stage disease, as prophylactic cranial irradiation for prevention of brain metastases, as consolidation to the chest in extensive stage disease, and for palliation.
Category
  • Lung Cancer
Format
  • Online SA-CME
Credits
  • 1.25 Certificate of Attendance
  • 1.25 SA-CME
A Systematic Review Into the Radiological Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients with Non-small Cell Lung Cancer (NSCLC)
This journal activity provides practitioners with the knowledge needed to better interpret imaging studies performed following lung SBRT and what features should lead to concern for local recurrence.
Category
  • Lung Cancer
Format
  • Journal SA-CME
Credits
  • 1.00 Certificate of Attendance
  • 1.00 SA-CME
Lung - Refresher 2022
Major decreases in cancer mortality have been driven by improvements in the management of lung cancer. The explanation for these survival improvements is complex but largely driven by the increasing use of systemic therapies in early stage disease such as immunotherapy.
Category
  • Lung Cancer
Format
  • Online SA-CME
Credits
  • 1.50 Certificate of Attendance
  • 1.50 SA-CME
The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases
This journal activity provides practitioners with the knowledge regarding recent treatment advances in lung cancer, including factors that may influence survival in patients with brain metastases with NSCLC and SCLC. It will also quantify how these factors impact survival.
Category
  • Lung Cancer
Format
  • Journal SA-CME
Credits
  • 1.00 Certificate of Attendance
  • 1.00 SA-CME